Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:precision_nanosystems [2022/07/12 15:58]
liam [COVID-19]
+++ pharmaceutical_companies:precision_nanosystems [2024/11/15 18:08] (current)
liam [External links]
@@ Line 3: / Line 3: @@
 {{ :pharmaceutical_companies:precision_nanosystemslogo.png?200|}}
-**Precision NanoSystems** is a Canadian biotechnology company based in [[:canada:british_columbia:Vancouver|Vancouver, British Columbia]]. The company was co-founded by [[:Pieter Cullis]], who also co-founded [[Acuitas Therapeutics]].((Cullis, P. (2019, June 25). //Innovation as a Driver for Personalized Medicine in British Columbia.// Reboot Communications. https://web.archive.org/web/20210713174744/https://www.rebootcommunications.com/wp-content/uploads/2019/06/Cullis-Kelowna-June-2019.pdf))
+**Precision NanoSystems Inc.** is a Canadian biotechnology company based in [[:canada:british_columbia:Vancouver|Vancouver, British Columbia]]. The company was co-founded by [[:Pieter Cullis]], who also co-founded [[Acuitas Therapeutics]].((Cullis, P. (2019, June 25). //Innovation as a Driver for Personalized Medicine in British Columbia.// Reboot Communications. https://web.archive.org/web/20210713174744/https://www.rebootcommunications.com/wp-content/uploads/2019/06/Cullis-Kelowna-June-2019.pdf)) His co-founders are [[:Euan Ramsay]] and [[:James Taylor]].
 The company develops genetic medicine-based therapies, including "self-assembling" molecules that carry drugs and gene therapies directly into the cells of the human body using DNA and RNA encapsulated in [[:covid-19_vaccines:lipid nanoparticle|lipid nanoparticles]].((//Create Transformative Medicines.// Precision NanoSystems. Retrieved March 8, 2022, from https://archive.ph/GgZY9)) ((Shore, R. (2016, February 25). //Vancouver-Based Nanomedicine Startup Targets Genetic Solution to Diseases.// Precision NanoSystems. https://archive.ph/QLpEO)) It was launched with assistance from [[:Genome British Columbia]].((//Annual Report 2020-2021.// Genome BC. Retrieved April 18, 2022, from https://web.archive.org/web/20210703114654/https://www.genomebc.ca/wp-content/uploads/2021/06/GBC-5198-2020-21-AR-FINAL_WEB.pdf))
 ===== History =====
+==== Founding ====
+Precision NanoSystems was founded in 2010 by [[:Pieter Cullis]], [[:Euan Ramsay]] and [[:James Taylor]].((Cullis, P. (2019, June 25). //Innovation as a Driver for Personalized Medicine in British Columbia.// Reboot Communications. https://web.archive.org/web/20210713174744/https://www.rebootcommunications.com/wp-content/uploads/2019/06/Cullis-Kelowna-June-2019.pdf)) ((//Precision NanoSystem - Crunchbase Company Profile & Funding.// Crunchbase. Retrieved February 7, 2023, from https://www.crunchbase.com/organization/precision-nanosystem))
 ==== COVID-19 ====
-On October 23, 2020, Prime Minister [[:Justin Trudeau]] announced that he had awarded the company $18.2 million from the [[:Government of Canada]] to Develop an [[:RNA vaccine|RNA vaccine]] for [[:COVID-19]].((Precision NanoSystems. (2020, October 26). //Prime Minister announces LSI spinoff to receive funding to develop an RNA Vaccine for COVID-19 | Life Sciences Institute.// University of British Columbia. https://lsi.ubc.ca/2020/10/26/prime-minister-announces-lsi-spinoff-to-receive-funding-to-develop-rna-vaccine-for-covid-19/)) The funding came from [[Innovation, Science and Economic Development Canada]]’s Strategic Innovation Fund (SIF), which focuses on supporting private sector-led vaccine and therapy clinical trials.
+On October 23, 2020, Prime Minister [[:Justin Trudeau]] announced that he had awarded the company $18.2 million from the [[:Government of Canada]] to develop an [[:RNA vaccine|RNA vaccine]] for [[:COVID-19]].((Precision NanoSystems. (2020, October 26). //Prime Minister announces LSI spinoff to receive funding to develop an RNA Vaccine for COVID-19 | Life Sciences Institute.// University of British Columbia. https://lsi.ubc.ca/2020/10/26/prime-minister-announces-lsi-spinoff-to-receive-funding-to-develop-rna-vaccine-for-covid-19/)) The funding came from [[:Innovation, Science and Economic Development Canada]]’s Strategic Innovation Fund (SIF), which focuses on supporting private sector-led vaccine and therapy clinical trials.
+The company was acquired by [[:Danaher]] on June 1, 2021.((//Precision NanoSystem - Crunchbase Company Profile & Funding.// Crunchbase. Retrieved February 7, 2023, from https://www.crunchbase.com/organization/precision-nanosystem))
+In July 2022, [[Replicate Bioscience]] issued a press release announcing a partnership with Precision NanoSystems to "accelerate the creation, scale-up, and delivery of [[:self-replicating RNA]] (srRNA) therapies."((Replicate Bioscience. (2022, July 26). //Precision NanoSystems and Replicate Bioscience in licensing deal to scale up genomic medicines.// Cision Newswire. https://web.archive.org/web/20230207015748/https://www.newswire.ca/news-releases/precision-nanosystems-and-replicate-bioscience-in-licensing-deal-to-scale-up-genomic-medicines-888682943.html))
+===== Organization =====
+==== Investors ====
+Investors in Precision NanoSystems include:((//Precision NanoSystem - Funding, Financials, Valuation & Investors.// Crunchbase. Retrieved February 7, 2023, from https://www.crunchbase.com/organization/precision-nanosystem/company_financials))
+  * [[:5AM Ventures]]
+  * [[:Accel-Rx]]
+  * [[:Northview LifeSciences]]
+  * [[:Rising Tide]]
+  * [[:Telegraph Hill Partners]]
+===== External links =====
+  * [[https://wiki.whiteroseintelligence.com/en/Precision-NanoSystems|White Rose Wiki]]